Search

Clinical Trials Community-based physicians will study promising HIV therapies at four new sites joining the community-based clinical trials network supported by the U.S. National Institute of Allergy and Infectious Diseases [...]

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced funding for 37 AIDS clinical trials units that will test drugs to fight infections with HIV and related illnesses [...]

Patients with cutaneous Kaposi's sarcoma are being enrolled in each of two studies investigating different treatment approaches to the disease. Both studies are being conducted by researchers in the Department [...]

R.A. Morgan, of the Clinical Gene Therapy Branch of the National Institutes of Health, Bethesda, Maryland, described in a recent issue of the journal Clinical and Experimental Immunology the development [...]

The Feasibility of HIV-1 Vaccine Efficacy Trials among Gay Bisexual Men in New York City: Project ACHIEVE." AIDS, November 1996;10(13):1555-1561. According to the authors' abstract of an article published in [...]

Advanced clinical trials of HIV vaccines should be conducted in developing nations, the United Nations argues. And through its UNAIDS organization, the U.N. is preparing to begin such trials in [...]

The design of AIDS clinical trials should incorporate new insights into HIV pathogenesis, according to researcher George Shaw of the University of Alabama at Birmingham. Studies independently published earlier this [...]

Clinical Trial Biomune Systems Inc., Salt Lake City, Utah, announced the signing of contracts between Biomune and the Salt Lake Clinic Research Foundation whereby the foundation will undertake Phase I [...]

DATELINE: United Kingdom British Bio-technology Group plc (BBG) has announced the start of the first trial of its experimental AIDS treatment, p24-VLP, in patients with advanced HIV infection, including AIDS. [...]

U.S. NIAID The AIDS Clinical Trials Group (ACTG) of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has selected six additional candidate sites for the proposed trial of [...]

The central point of contention between the pharmaceutical industry and the U.S. National Institute of Allergy and Infectious Diseases (NIAID) is access to data, the chair of an industry panel [...]

VIII International Conference on AIDS "The momentum of the AIDS epidemic suggests that now is the time to prepare the necessary infrastructure for large trials to assess the effectiveness of [...]

SOURCE: Annals of Internal Medicine, April 1, 1992;116(7):599-601. Although there is an "intensive" search for surrogate markers, clinical outcomes must still be used to evaluate clinical trials of AIDS therapies, [...]

Interferon Sciences, Inc. (ISI), New Brunswick, New Jersey, announced that patient enrollment has commenced in a multi-center, open label, Phase II clinical trial designed to evaluate the safety and efficacy [...]

Procept, Inc., Cambridge, Massachusetts, announced that the Company has initiated enrollment of patients in a new Phase I/II clinical trial in Europe to evaluate the safety and efficacy of PRO [...]

According to the authors' abstract of an article published in AIDS, "OBJECTIVE: To genetically characterize HIV-1 strains in injecting drug users (IDU) in Bangkok, Thailand in 1994, and compare these [...]

A Florida company is looking for 21 Atlantas who do not have HIV to test a potential vaccine for the disease. The company says there is no chance of getting [...]

Pediatric AIDS Clinical Trials Program AUTHORS: RFA Available: AI-92-14. National Institute of Allergy and Infectious Diseases. "Letter of Intent Receipt Date: November 16, 1992. Application Receipt Date: January 21, 1993. [...]

AUTHORS: RFA Available: AI-92-10. National Institute of Allergy and Infectious Diseases. "Letter of Intent Receipt Date: November 13, 1992. Preapplication Meeting Date: December 7, 1992. Application Receipt Date: January 21, [...]